Suven Pharmaceuticals Ltd Q3 FY2023-2024 Results: Summary
Revenue | ₹234.16Cr |
Net Profits | ₹46.75Cr |
Net Profit Margins | 19.96% |
Highlights
Revenue:
Suven Pharmaceuticals Ltd’s revenue fell -36.16% since last year same period to ₹234.16Cr in the Q3 2023-2024. On a quarterly growth basis, Suven Pharmaceuticals Ltd has generated -6.67% fall in its revenue since last 3-months.
Net Profits:
Suven Pharmaceuticals Ltd’s net profit fell -56.6% since last year same period to ₹46.75Cr in the Q3 2023-2024. On a quarterly growth basis, Suven Pharmaceuticals Ltd has generated -41.24% fall in its net profits since last 3-months.
Net Profit Margins:
Suven Pharmaceuticals Ltd’s net profit margin fell -32.02% since last year same period to 19.96% in the Q3 2023-2024. On a quarterly growth basis, Suven Pharmaceuticals Ltd has generated -37.04% fall in its net profit margins since last 3-months.
